N201 - TCRCure
LYC001 - Liangyuan Bioscience
izalontamab brengitecan (BL-B01D1) - Biokin Pharma, BMS
QH101 - Beijing Qinghui Liannuo Biotechnology
MT027 - Suzhou Maximum Bio-tech
IBI-363 - Innovent Biologics, Takeda
tirbanibulin oral (KX-01 oral) - Athenex
TAEST1901 - Guangzhou Xiangxue Pharma
KXV01 TCR lentinvivo - TCRx Therap
GV20-0251 - GV20 Therap
CVL-006 - Convalife
YSCH-01 - Shanghai Yuansong Biotech
IDOV-Safe - ViroMissile
http://clinicaltrials.gov/ct2/show/NCT07307053
 
Dec 30, 2025
 
Next